SELLAS Life Sciences (SLS) Accumulated Expenses (2019 - 2024)
Historic Accumulated Expenses for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $5.5 million.
- SELLAS Life Sciences' Accumulated Expenses fell 2076.78% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 2076.78%. This contributed to the annual value of $7.6 million for FY2023, which is 2169.9% up from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences' Accumulated Expenses is $5.5 million, which was down 2076.78% from $5.2 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences' Accumulated Expenses registered a high of $7.6 million during Q4 2023, and its lowest value of $888000.0 during Q1 2020.
- For the 5-year period, SELLAS Life Sciences' Accumulated Expenses averaged around $4.1 million, with its median value being $3.0 million (2022).
- As far as peak fluctuations go, SELLAS Life Sciences' Accumulated Expenses skyrocketed by 18682.43% in 2021, and later crashed by 2076.78% in 2024.
- SELLAS Life Sciences' Accumulated Expenses (Quarter) stood at $1.9 million in 2020, then soared by 38.0% to $2.6 million in 2021, then skyrocketed by 138.11% to $6.3 million in 2022, then increased by 21.7% to $7.6 million in 2023, then fell by 28.24% to $5.5 million in 2024.
- Its Accumulated Expenses was $5.5 million in Q3 2024, compared to $5.2 million in Q2 2024 and $6.5 million in Q1 2024.